In this article, we are going to discuss the 12 high yield Fortune 500 stocks to buy now.
The 2026 Fortune 500 rankings dropped earlier this month, and it showed that collectively, these companies pulled in $21 trillion in revenue, a 5% increase from last year, while profits climbed a steeper 12% to hit $2.1 trillion. Their combined market value now stands at $55 trillion, nearly a fifth more than it was a year ago. To put that in perspective, these 500 companies account for roughly two-thirds of everything the US economy produces, and they employ 30.5 million people worldwide.
The biggest shake-up at the top: Amazon has replaced Walmart from the No. 1 spot after 13 straight years. It is worth remembering that Amazon first cracked this list back in 2002, sitting at No. 492. Walmart, meanwhile, settles into second place, a ranking it has not occupied since 2012.
Power, however, is increasingly concentrated at the very top. Alphabet, Nvidia, Apple, and Meta each crossed $100 billion in profits individually, together accounting for $466 billion, or about 22 cents of every dollar the entire Fortune 500 earned.
On the leadership front, a record 55 Fortune 500 companies are now led by women. That is 11% of the list, and the fourth consecutive year that the share has held at or above that mark.
With that said, here are the Best Fortune 500 Dividends Stocks to Buy in 2026.

Photo by Viacheslav Bublyk on Unsplash
Our Methodology
To collect data for this article, we scanned the top companies among the Fortune Global Rankings and shortlisted dividend stocks with an annual yield of at least 2.50%, as of June 11. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. The following are the Best Fortune 500 Dividend Stocks to Buy Now.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
12. International Business Machines Corporation (NYSE:IBM)
Dividend Yield as of June 11: 2.50%
International Business Machines Corporation (NYSE:IBM) is a provider of global hybrid cloud and AI and consulting expertise.
On June 8, BofA analyst Wamsi Mohan boosted the firm’s price target on International Business Machines Corporation (NYSE:IBM) from $300 to $315, while keeping a ‘Buy’ rating on the shares. The revised objective represents an upside of over 15% from the current share price.
BofA believes that the demand for AI infrastructure continues to be broader, deeper, and more durable. The analyst firm raised its price targets on several tech stocks following the bullish sentiment surrounding the strong long-term demand trends expressed by industry experts at the BofA 2026 Global Technology Conference.
International Business Machines Corporation (NYSE:IBM) continues to bolster its position in cutting-edge technologies and disclosed last month that it would invest $10 billion into quantum computing over the next five years. The move follows a letter of intent between the company and the US federal government to build a quantum chip foundry in the country. IBM also revealed that it would put $5 billion towards an AI-linked open-source software project.
11. CVS Health Corporation (NYSE:CVS)
Dividend Yield as of June 11: 2.65%
America’s leading health solutions company, CVS Health Corporation (NYSE:CVS), provides advanced health care from pharmacy services and health plans to health and wellness.
On June 8, Mizuho upped its price target on CVS Health Corporation (NYSE:CVS) from $110 to $115, and maintained its ‘Outperform’ rating on the shares. The revised target indicates an upside of over 14% from the current price level.
According to Mizuho, the managed care industry is going into a “more stable and predictable” policy backdrop. The analyst firm believes that the severity and frequency of policy-related surprises should ease down from the unusually high levels seen over the past three years. This should allow investors to focus on the company fundamentals, pricing recovery, and the underlying earnings potential of the overall sector.
As a result, Mizuho boosted its price targets across the managed care sector to reflect the more stable regulatory and legislative environment.
CVS Health Corporation (NYSE:CVS) has grown its dividends by 56.5% over the last decade and boasts an impressive annual yield of 2.65%. This makes it especially attractive for institutional investors and puts it among the 12 Best Dividend Stocks to Invest In According to Hedge Funds.






